Thermage, Inc. (THRM)

[surf1944]

Thermage Announces Technological Advances Featured at ASLMS Meeting
Thursday April 3, 8:00 am ET

KISSIMMEE, Fla., April 3, 2008 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM - News) today announced that physician investigators will be presenting clinical research using Thermage technology during the 28th Annual Conference for the American Society for Laser Medicine & Surgery (ASLMS), from both the podium and during a Thermage organized symposium featuring leading experts in the field.

Topics covered during the meeting include advances in skin tightening technology, clinical outcomes using the deep contouring tip for Body Shape procedures and the new treatment for cellulite. Additionally research will be presented on how Thermage technology may be applied for future applications such as fat reduction.

Thermage technology will be featured in the following sessions:

-- Anne C. Chapas, M.D., Skin Rejuvenation Session April 3rd
8 a.m. - 12 p.m.

-- Robert A. Weiss, M.D. Skin Rejuvenation Session April 3rd
8 a.m. - 12 p.m.

-- Christopher Zachary, M.D. "Effects of Monopolar Radiofrequency on the
subcutaneous fat layer in an animal model", Cutaneous Laser Surgery
Session April 6th 8.55 a.m.


Clinical studies accepted as poster presentations include:

-- Sofia Rubbani, M.D. "Advances in Monopolar Radiofrequency for the
treatment of stretch marks in the arms, thighs and abdomens"

-- Neil Saddick, M.D "Immediate effect of a new monopolar radiofrequency
treatment tip on cellulite"


The Thermage Symposium will be held on Thursday April 3rd at 7pm at the Gaylord Palms Resort, Osceola B. The symposium will be moderated by Jeffrey Dover, M.D and will feature Robert Weiss, M.D, Karyn Grossman, M.D and Suzanne Bruce, M.D. The symposium will cover how continual innovation has maintained Thermage technology as the gold standard in skin tightening and contouring for face and body. There will also be a discussion on how Thermage technology and these new applications can be integrated into an aesthetic practice.

"Thermage is dedicated to continual innovation to expand our platform with new applications and to drive the efficacy and value of our products to meet the needs of our customers," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "The clinical findings being presented at ASLMS are a testament to our commitment to commercialize products that are based on thorough scientific and clinical research as well as our long-standing partnerships with pre-eminent researchers and practitioners in the field."